NewsFree365
--°
Business
1 views

A New Drug Takes Aim At One Of Cancer’s Most Difficult Targets

FDA-approved daraxonrasib targets RAS in metastatic pancreatic cancer, doubling median survival versus chemotherapy and delivering a long-awaited treatment advance.

A New Drug Takes Aim At One Of Cancer’s Most Difficult Targets
Forbes Verified Source

Reported by William A. Haseltine, Contributor · Syndicated via official news feed

Explore all Business stories

Syndicated feed content with full publisher credit.

Live Newsroom Broadcast48,500+ Active Readers

Breaking News Sent Directly To Your Phone

Get instant market movers, policy notifications, and verified alerts delivered straight to your WhatsApp and Telegram feeds before algorithms filter them.

Sub-Second Flash Alerts100% Privacy & Zero SpamFree Forever
Business Desk

More in Business

Continue reading verified coverage and related developments on this desk.

View All